FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen.
Kuehn
Bridget M
BM
D000082:Acetaminophen / Q000009:adverse effects*; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D013956:Antithyroid Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control; D004348:Drug Labeling; D055106:Genome-Wide Association Study; D006801:Humans; D008285:Major Histocompatibility Complex; D011441:Propylthiouracil / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D018712:Analgesics, Non-Narcotic; D013956:Antithyroid Agents; D000082:Acetaminophen; D011441:Propylthiouracil